- Home
- FCAP vs ALEC Comparison
FCAP vs ALEC Comparison
Compare FCAP & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCAP
- ALEC
- Stock Information
- Founded
- FCAP 1891
- ALEC 2013
- Country
- FCAP United States
- ALEC United States
- Employees
- FCAP N/A
- ALEC N/A
- Industry
- FCAP Savings Institutions
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FCAP Finance
- ALEC Health Care
- Exchange
- FCAP Nasdaq
- ALEC Nasdaq
- Market Cap
- FCAP 125.9M
- ALEC 124.0M
- IPO Year
- FCAP 1999
- ALEC 2019
- Fundamental
- Price
- FCAP $44.01
- ALEC $1.27
- Analyst Decision
- FCAP
- ALEC Hold
- Analyst Count
- FCAP 0
- ALEC 9
- Target Price
- FCAP N/A
- ALEC $3.40
- AVG Volume (30 Days)
- FCAP 3.6K
- ALEC 5.3M
- Earning Date
- FCAP 10-24-2025
- ALEC 11-06-2025
- Dividend Yield
- FCAP 2.80%
- ALEC N/A
- EPS Growth
- FCAP 25.19
- ALEC N/A
- EPS
- FCAP 4.41
- ALEC N/A
- Revenue
- FCAP $47,323,000.00
- ALEC $69,048,000.00
- Revenue This Year
- FCAP N/A
- ALEC N/A
- Revenue Next Year
- FCAP N/A
- ALEC $314.69
- P/E Ratio
- FCAP $10.07
- ALEC N/A
- Revenue Growth
- FCAP 15.22
- ALEC 12.26
- 52 Week Low
- FCAP $28.50
- ALEC $0.87
- 52 Week High
- FCAP $53.85
- ALEC $6.14
- Technical
- Relative Strength Index (RSI)
- FCAP 57.27
- ALEC 25.95
- Support Level
- FCAP $42.71
- ALEC $1.45
- Resistance Level
- FCAP $44.00
- ALEC $1.34
- Average True Range (ATR)
- FCAP 0.80
- ALEC 0.15
- MACD
- FCAP 0.20
- ALEC -0.06
- Stochastic Oscillator
- FCAP 100.00
- ALEC 4.52
About FCAP First Capital Inc.
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.